One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Total Iron Binding Capacity Reagents Market

[ 英語タイトル ] Total Iron Binding Capacity Reagents Market - Growth, Trends, and Forecast (2020 - 2025)


Product Code : MDHC0089311
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 117
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form

[Report Description]

The total iron binding capacity reagents market is expected to register a CAGR of 5% during the forecast period. Total iron-binding capacity is used to check the iron content in the bloodstream. This is a type of blood test performed to check the blood flow and related disorders.

- The increasing prevalence of iron deficiency anemia has been driving the growth of total iron-binding capacity reagents markets, as these tests have been carried out to check the diseases.
- Iron deficiency anemia is common in women population due to menstrual cycle, boosting the TIBC reagents market.
- Moreover, chemotherapy is also one of the factors for iron deficiency anemia due to the reduced iron content and blood loss because of the inflammatory process associated with cancer treatment.
- Chemotherapy and radiotherapy often deplete iron contents, which further boosts the revenue growth of the total iron-binding capacity reagents market.

Key Market Trends

Iron Deficiency Anemia Segment is Expected to Hold a Significant Market Share in the Total Iron Binding Capacity Reagents Market.

The increasing prevalence of iron deficiency anemia has been promoting the growth of the total iron-binding capacity reagents market. As per the World Health Organization (WHO), anemia is a common disease affecting around 24.8% of the total population. This results in the adoption of these tests for diagnosis, thereby, boosting the segment growth of the TIBC reagents market. Moreover, It is very important to maintain iron levels in the body, as the human body needs iron for oxygen transport. These tests have been widely used to diagnose the targeted patient pool, and hence, drive the revenue growth of the total iron binding capacity reagent market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global total iron binding capacity reagents market due to the increasing prevalence of iron deficiency anemia in this region. The need to reduce the burden of iron deficiency anemia had led to an increase in demand for its treatment, thereby, promoting the growth of the total iron-binding capacity reagents market. The prevalence of anemia is a substantial public health indicator and has remained a relevant health concern in the United States. Since 1990, the prevalence rate of  iron deficiency anemia in US infants did not drop, making iron deficiency a significant public health problem in the United States. This increasing prevalence rate of iron deficiency anemia may drive the overall market in this region.

Competitive Landscape

Some of the companies that are currently dominating the market Randox Laboratories Ltd, Biosystems SA, McKesson Medical-Surgical Inc., Sekisui Diagnostics LLC, Thermo Fisher Scientific, Henry Schein, and Diagnostic Systems GmbH, among others.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Patient Pool Suffering from the Acute and Iron Deficiency
4.2.2 Increasing R&D Expenditure
4.3 Market Restraints
4.3.1 Limited Product Availability and Time Consuming Nature of the TIBC Assays
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Disease Type
5.1.1 Iron Deficiency Anemia
5.1.2 Iron Deficiency in Late Pregnancy
5.2 By End User
5.2.1 Diagnostic Laboratories
5.2.2 Hospitals
5.2.3 Clinics
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Randox Laboratories Ltd
6.1.2 Biosystems SA
6.1.3 McKesson Medical-Surgical Inc.
6.1.4 Sekisui Diagnostics LLC
6.1.5 Thermo Fisher Scientific
6.1.6 Henry Schein
6.1.7 Diagnostic Systems GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+